A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics
Neurodegenerative disorders are primarily characterized by neuron loss. The most common
neurodegenerative disorders include Alzheimer's and Parkinson's disease. Although there …
neurodegenerative disorders include Alzheimer's and Parkinson's disease. Although there …
Alzheimer's disease and its treatment by different approaches: A review
Alzheimer's disease (AD) is a neurodegenerative disorder that impairs mental ability
development and interrupts neurocognitive function. This neuropathological condition is …
development and interrupts neurocognitive function. This neuropathological condition is …
Recent applications of PLGA based nanostructures in drug delivery
Over the years, issues associated with non-biodegradable polymers have paved the way for
biodegradable polymers in the domain of pharmaceutical and biomedical sciences. Poly …
biodegradable polymers in the domain of pharmaceutical and biomedical sciences. Poly …
Advancements in nanotherapeutics for Alzheimer's disease: current perspectives
Objectives Considerable progress has been made in the treatment of Alzheimer's disease
(AD), but all available strategies focus on alleviating symptoms rather than curing, which …
(AD), but all available strategies focus on alleviating symptoms rather than curing, which …
Chitin and chitosan derivatives as biomaterial resources for biological and biomedical applications
S Satitsri, C Muanprasat - Molecules, 2020 - mdpi.com
Chitin is a long-chain polymer of N-acetyl-glucosamine, which is regularly found in the
exoskeleton of arthropods including insects, shellfish and the cell wall of fungi. It has been …
exoskeleton of arthropods including insects, shellfish and the cell wall of fungi. It has been …
Concepts and practices used to develop functional PLGA-based nanoparticulate systems
H Sah, LA Thoma, HR Desu, E Sah… - International journal of …, 2013 - Taylor & Francis
The functionality of bare polylactide-co-glycolide (PLGA) nanoparticles is limited to drug
depot or drug solubilization in their hard cores. They have inherent weaknesses as a drug …
depot or drug solubilization in their hard cores. They have inherent weaknesses as a drug …
Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases
A Cano, E Sanchez-Lopez, M Ettcheto… - …, 2020 - Taylor & Francis
Effective intervention is essential to combat the coming epidemic of neurodegenerative (ND)
diseases. Nanomedicine can overcome restrictions of CNS delivery imposed by the blood …
diseases. Nanomedicine can overcome restrictions of CNS delivery imposed by the blood …
Therapeutic potential of phytoconstituents in management of Alzheimer's disease
Since primitive times, herbs have been extensively used in conventional remedies for
boosting cognitive impairment and age‐associated memory loss. It is mentioned that …
boosting cognitive impairment and age‐associated memory loss. It is mentioned that …
Nanomaterials for reducing amyloid cytotoxicity
This review is intended to reflect the recent progress on therapeutic applications of
nanomaterials in amyloid diseases. The progress on anti‐amyloid functions of various …
nanomaterials in amyloid diseases. The progress on anti‐amyloid functions of various …
Exosome-based approaches in the management of Alzheimer's disease
Alzheimer's disease (AD) has been the most extensively studied neurological disorders that
affects millions of individuals globally and is associated with misfolding of proteins in the …
affects millions of individuals globally and is associated with misfolding of proteins in the …